Application Nr Approved Date Route Status External Links
ANDA074759 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Aminocaproic Acid Is Useful In Enhancing Hemostasis When Fibrinolysis Contributes To Bleeding. In Life-Threatening Situations, Transfusion Of Appropriate Blood Products And Other Emergency Measures May Be Required. Fibrinolytic Bleeding May Frequently Be Associated With Surgical Complications Following Heart Surgery (With Or Without Cardiac Bypass Procedures) And Portacaval Shunt; Hematological Disorders Such As Amegakaryocytic Thrombocytopenia (Accompanying Aplastic Anemia); Acute And Life-Threatening Abruptio Placentae; Hepatic Cirrhosis; And Neoplastic Disease Such As Carcinoma Of The Prostate, Lung, Stomach, And Cervix. Urinary Fibrinolysis, Usually A Normal Physiological Phenomenon, May Contribute To Excessive Urinary Tract Fibrinolytic Bleeding Associated With Surgical Hematuria (Following Prostatectomy And Nephrectomy) Or Nonsurgical Hematuria (Accompanying Polycystic Or Neoplastic Diseases Of The Genitourinary System). (See Warnings ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Aminocaproic Acid

Comments